[Cancer: when recycling becomes a weakness].
Sonveaux
Pierre
P
Végran
Frédérique
F
Verrax
Julien
J
De Saedeleer
Christophe J
CJ
Diepart
Caroline
C
Jordan
Bénédicte F
BF
Gallez
Bernard
B
Feron
Olivier
O
D000818:Animals; D000964:Antimetabolites, Antineoplastic / Q000494:pharmacology / Q000627:therapeutic use; D016923:Cell Death; D002455:Cell Division; D015687:Cell Hypoxia; D002471:Cell Transformation, Neoplastic; D003131:Combined Modality Therapy; D003373:Coumaric Acids / Q000494:pharmacology / Q000627:therapeutic use; D004249:DNA Damage / Q000528:radiation effects; D018450:Disease Progression; D004734:Energy Metabolism / Q000187:drug effects; D006019:Glycolysis; D006801:Humans; D007773:Lactates / Q000378:metabolism; D051379:Mice; D027501:Monocarboxylic Acid Transporters / Q000037:antagonists & inhibitors / Q000502:physiology; D009363:Neoplasm Proteins / Q000037:antagonists & inhibitors / Q000502:physiology; D009369:Neoplasms / Q000378:metabolism* / Q000473:pathology; D009374:Neoplasms, Experimental / Q000188:drug therapy / Q000378:metabolism / Q000532:radiotherapy; D034741:RNA, Small Interfering / Q000494:pharmacology / Q000627:therapeutic use; D012641:Selection, Genetic; D027981:Symporters / Q000037:antagonists & inhibitors / Q000502:physiology; D000099233:Monocarboxylate Transport Protein 1
D000964:Antimetabolites, Antineoplastic; D003373:Coumaric Acids; D007773:Lactates; D027501:Monocarboxylic Acid Transporters; D009363:Neoplasm Proteins; D034741:RNA, Small Interfering; D027981:Symporters; D000099233:Monocarboxylate Transport Protein 1; C007175:alpha-cyano-4-hydroxycinnamate